We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

105 hedge funds and large institutions have $136M invested in VanEck Biotech ETF in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $355K

15% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 26

11% more capital invested

Capital invested by funds: $123M → $136M (+$13.4M)

2.41% more ownership

Funds ownership: 25.65% → 28.06% (+2.4%)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

3% less funds holding

Funds holding: 108 → 105 (-3)

Holders
105
Holders Change
-3
Holders Change %
-2.78%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
30
Reduced
26
Closed
9
Calls
$1.37M
Puts
$355K
Net Calls
+$1.01M
Net Calls Change
+$1.25M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$9.04M
2
FP
Financial Perspectives
Minnesota
+$2.78M
3
FFN
Focus Financial Network
Minnesota
+$2.52M
4
HighTower Advisors
HighTower Advisors
Illinois
+$1.91M
5
GT
Glenview Trust
Kentucky
+$1.68M

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.8M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.34M
3
Citadel Advisors
Citadel Advisors
Florida
-$976K
4
RJA
Raymond James & Associates
Florida
-$720K
5
HPCM
Hunter Perkins Capital Management
Illinois
-$556K
Name Holding Trade Value Shares
Change 		Change in
Stake
SFPG
26
Stonebridge Financial Planning Group
Florida
$1.24M +$45.2K +250 +4%
CM
27
Columbus Macro
Pennsylvania
$1.23M -$12.3K -68 -1%
Ameriprise
28
Ameriprise
Minnesota
$1.2M +$43.4K +240 +4%
IFWM
29
Institute for Wealth Management
Colorado
$1.2M +$23K +127 +2%
RJFSA
30
Raymond James Financial Services Advisors
Florida
$1.08M +$24.2K +134 +2%
Wells Fargo
31
Wells Fargo
California
$1.07M +$16.3K +90 +1%
GJIC
32
Gamble Jones Investment Counsel
California
$1.05M – – –
ACA
33
Atlas Capital Advisors
Wyoming
$1.05M – – –
SBH
34
Segall Bryant & Hamill
Illinois
$902K – – –
PNC Financial Services Group
35
PNC Financial Services Group
Pennsylvania
$900K – – –
AL
36
Aspiriant LLC
California
$733K -$29.5K -163 -4%
NWA
37
Navis Wealth Advisors
New York
$685K +$193K +1,065 +38%
SC
38
Scotia Capital
Ontario, Canada
$673K +$43.2K +239 +7%
IAMOG
39
Investors Asset Management of Georgia
Georgia
$649K – – –
Northern Trust
40
Northern Trust
Illinois
$641K +$54.2K +300 +9%
Truist Financial
41
Truist Financial
North Carolina
$613K +$25.5K +141 +4%
Cetera Investment Advisers
42
Cetera Investment Advisers
Illinois
$609K -$3.98K -22 -0.6%
FNBOSM
43
First National Bank of South Miami
Florida
$607K -$55.9K -309 -8%
Osaic Holdings
44
Osaic Holdings
Arizona
$585K +$199K +1,102 +49%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$570K +$26.2K +145 +5%
WJWM
46
Williams Jones Wealth Management
New York
$554K – – –
TC
47
Telemus Capital
Michigan
$545K +$3.62K +20 +0.7%
PAG
48
Private Advisor Group
New Jersey
$475K -$36.2K -200 -7%
Cambridge Investment Research Advisors
49
Cambridge Investment Research Advisors
Iowa
$408K -$130K -717 -24%
BPA
50
Beacon Pointe Advisors
California
$386K – – –
1
2
3 4 5

BBH Hedge Fund Activity: Q1 2021 in Review

105 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2021, worth a combined $136M — up 11% from $123M a quarter earlier.

Fund positioning in BBH was balanced in Q1 2021: 9 funds opened new positions, 9 closed out, 30 added to existing stakes and 26 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $9.04M. The largest seller was Royal Bank of Canada, cutting an estimated $1.8M.

  • 105 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2021, down from 108 in Q4 2020.
  • Funds reported $136M of VanEck Biotech ETF stock for Q1 2021, up 11% quarter-over-quarter.
  • 9 funds opened new VanEck Biotech ETF positions in Q1 2021 and 9 closed out, a net change of 0 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2021 was Goldman Sachs, an estimated $9.04M added.
  • The largest VanEck Biotech ETF seller in Q1 2021 was Royal Bank of Canada, an estimated $1.8M sold.

Based on aggregated 13F filings for Q1 2021.